Dendritic cell vaccination as postremission treatment to prevent or delay relapse in acute myeloid leukemia
/in Acute Leukemia, Dendritic Cells, International Publications /von 2017-08-22 / Blood 2017 10;130(15):1713-1721Macrophage Polarization Contributes to Glioblastoma Eradication by Combination Immunovirotherapy and Immune Checkpoint Blockade
/in Checkpoint-Inhibitors, Glioblastoma, International Publications, Newcastle Disease Virus /von 2017-08-14 / Cancer Cell 2017 08;32(2):253-267.e5Dendritic cell vaccination for metastatic melanoma: a 14-year monoinstitutional experience
/in Dendritic Cells, International Publications, Malignant Melanoma /von 2017-08-01 / Melanoma Res 2017 08;27(4):351-357
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Das IOZK
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- Recent developments in targeting breast cancer stem cells (BCSCs): a descriptive review of therapeutic strategies and emerging therapies
- Neoantigen-targeted dendritic cell vaccination in lung cancer patients induces long-lived T cells exhibiting the full differentiation spectrum
- Individualized Multimodal Immunotherapy (IMI): Scientific Rationale and Clinical Experience from a Single Institution